mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00093 |
1 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0012 |
1 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.0007 |
1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0007 |
1 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.0041 |
1 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.00069 |
1 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.0003 |
1 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-9.6e-05 |
1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
6.5e-05 |
1 |